Medifast, Inc. reports developments as a metabolic health and wellness company built around the OPTAVIA science-backed, coach-guided lifestyle system. Its updates center on revenue trends, gross margin, active earning coaches, coach productivity and the company's shift toward metabolic health amid changes in weight-loss demand and GLP-1 medication adoption.
Recurring company news also covers OPTAVIA program evidence, nutrition and habit-creation offerings, HSA/FSA reimbursement availability on select insurance plans, independent coach community initiatives, media content tied to metabolic health, and governance matters such as board nominations and stockholder cooperation agreements.
Medifast (NYSE: MED) has appointed Lauren Walker as Executive Vice President of Supply Chain Operations, effective Sept. 21, 2020. Walker, previously Chief Supply Chain Officer at Young Living Essential Oils, will oversee Medifast's global supply chain organization. CEO Dan Chard expressed confidence in her ability to drive operational excellence. Walker's extensive experience includes roles at Amway, Procter & Gamble, and Johnson & Johnson. This leadership change is expected to enhance Medifast's operational capabilities and support its growth strategy.
Medifast (NYSE: MED) has declared a quarterly cash dividend of $1.13 per share, slated for payment on November 6, 2020, to stockholders on record as of September 22, 2020. The company aims to maintain its quarterly dividend program, subject to Board discretion. Medifast continues to grow through its wellness community, OPTAVIA®, and aims for strategic expansion, particularly in the Asia-Pacific region. This dividend declaration reflects the company's ongoing commitment to shareholder returns.
Medifast (NYSE: MED) reported a strong second quarter for 2020, with revenue increasing by 17.6% to $220.0 million. The company experienced a 19.3% rise in active earning OPTAVIA Coaches, totaling 36,500. Net income rose 2.6% to $21.9 million, with earnings per diluted share of $1.86, marking a 6.3% increase. Despite higher promotional costs impacting gross profit margins, which fell to 72.4%, Medifast's cash position improved to $145.4 million. A quarterly cash dividend of $1.13 per share was declared, emphasizing the company's commitment to returning value to shareholders.
Medifast (NYSE: MED) hosted its OPTAVIA Together Live event from July 24-26, 2020, attracting over 50,000 global registrants amidst the pandemic. The event featured educational sessions and panel discussions, achieving 140,000 views on Facebook. CEO Dan Chard emphasized the community's resilience and the company's strategic focus on an integrated coach model, which has nearly tripled revenue since 2016. Medifast will announce its Q2 2020 financial results on August 5, 2020, showcasing its ongoing growth in the health and wellness sector.
Medifast, Inc. (NYSE: MED) plans to release its financial results for Q2 2020, ending June 30, on August 5, 2020, after market close. The announcement will be followed by a conference call at 4:30 p.m. ET to discuss the results, featuring CEO Dan Chard and CFO Jim Maloney. The call can be accessed live on Medifast's investor relations website, with an archived version available until August 19, 2020. The results will shed light on the company’s performance and growth strategies impacted by its expanding health and wellness community, OPTAVIA®.
Medifast, Inc. (NYSE: MED) has appointed Jim Maloney as the new Chief Financial Officer, effective July 20, 2020. Maloney will oversee financial planning, capital allocation strategies, and investor relations. His extensive background includes leadership roles at L.B. Foster and H.J. Heinz, where he focused on financial management and building value. CEO Dan Chard stated that Maloney's experience will support Medifast's mission of delivering sustainable growth through its OPTAVIA® community, which promotes lifelong healthy habits.
Summary not available.
Medifast, Inc. (NYSE: MED) has declared a quarterly cash dividend of $1.13 per share, payable on August 6, 2020, to stockholders of record by June 30, 2020. The company aims to continue its quarterly dividend program, although future declarations are subject to the Board of Directors' discretion based on relevant factors. Medifast is recognized for its OPTAVIA® health and wellness community, which focuses on sustainable healthy habits and has seen significant growth.